De Novo Determination of the Crystal Structure of a Large Drug Molecule by Crystal Structure Prediction-Based Powder NMR Crystallography

The crystal structure of form 4 of the drug 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid is determined using a protocol for NMR powder crystallography at natural isotopic abundance combining solid-state H-1 NMR spectroscopy, crystal structure prediction, and density functional theory chemical shift calculations. This is the first example of NMR crystal structure determination for a molecular compound of previously unknown structure, and at 422 g/mol this is the largest compound to which this method has been applied so far.


Publié dans:
Journal of the American Chemical Society, 135, 46, 17501-17507
Année
2013
Publisher:
AMER CHEMICAL SOC
ISSN:
0002-7863
Laboratoires:




 Notice créée le 2015-01-08, modifiée le 2019-05-27


Évaluer ce document:

Rate this document:
1
2
3
 
(Pas encore évalué)